Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 79
  • Journal CiteScore: 29.12
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +447482874092

Short Communication - (2021) Volume 0, Issue 0

Early Detection of Pancreatic Cancer in Patient

Jianjun Han

1Department of Surgery, Harbin Medical University Cancer Hospital Harbin, China

Corresponding Author:
Jianjun Han
Department of Surgery
Harbin Medical University Cancer Hospital
Harbin, China
Tel: +86-773-3251158
E-mail: [email protected]

Received Date: August 09th, 2021; Accepted Date: August 31st, 2021

Visit for more related articles at Journal of the Pancreas


Receiving a diagnosis of cancer is known to cause depression within the patient due to the present situations and uncertainty this diagnosis brings. Anecdotal reports of melancholy before a cancer diagnosis have brought on researchers to take into account depression as a probable early sign that there is a disease inside the body. The depression earlier than-diagnosis courting is especially first-rate in pancreatic cancer, which has very few signs and symptoms and frequently is a systemic disease on the time of detection. An overview of the literature substantiates that depression and anxiety may be capability precursors to a pancreatic cancer analysis. Studies have started to appearance more intently at this link, with an eye to developing a testable marker for pancreatic cancer. Pancreatic cancer is the third leading cause of cancer death, with a 2-8 months relative survival rate of 6% [1]. Approximately 72% of people identified with pancreatic cancer are aged 52 years and older [2]. The disease is potentially curable by doing surgical treatment to remove the tumor. Even though pancreatic cancer is assumed to expand slowly over a prolonged period, [3] symptoms of the disease generally present only 12 weeks before analysis. Maximum patients are identified when the cancer is in its advanced ranges- after it has spread beyond the pancreas. With earlier detection, survival charges are reported to improve considerably. There are numerous motives pancreatic cancer is challenging to diagnose early. Due to the fact the pancreas is located deep in the frame, a tumor is hard to palpate on examination. Signs and symptoms because of a tumor are indistinct and just like symptoms from many different conditions. Before being identified, patient can also lose weight, feel nauseous, and have indigestion or pain when they consume food, have stomach or lower back pain, suffer from fatigue, or increase in diabetes. These kinds of symptoms could have other causes [4]. Regularly, human beings do no longer see a health practitioner till the bile duct is blocked. Bile duct blockages produce precise signs and symptoms, inclusive of jaundice, dark-colored urine, and light-colored stool. Whether or not severe pain or signs and symptoms together with jaundice send a patient to the health practitioner, through that point, the cancer has metastasized. One area that merits closer examination is the connection among pancreatic cancer, depression, and anxiety. Many researches have looked at depression after a cancer diagnosis. But, different studies have indicated that patient document onset of psychiatric signs earlier than a pancreatic cancer prognosis [5]. A literature assessment clarifies this relationship and points to a probable course for similarly research.


Earlier diagnosis of pancreatic cancer has proved to be challenging, and development has been slow. research supported with the aid of the government, industry, studies institutions, and philanthropy are actually taking part to acquire serum samples [6], perceive biomarkers, and broaden noninvasive imaging to confront this disease, giving wish that inside the now not too remote destiny, there may be consensus suggestions for earlier interception. Inside the period in-between, an anticipated 50,260 people have been recognized with pancreatic cancer in 2019, and an expected 33,000 lost their lives to the disease. Pancreatic cancer has mocked and teased us involved in too long. We need to make bigger our knowledge of the disease, respect its holistic effect at the body and mind, and no longer neglect the diffused clues it communicates. Depression and tension as ability precursors for ailment presents 1 extra piece of a complex puzzle to ensure well timed prognosis of pancreatic cancer and to improve survival.

Conflicts of Interest

The authors declare no competing interest.